255 followers
A randomized, phase IIa exploratory trial to assess efficacy of LEO 43204 in patients with AK. - PubMed - NCBI https://t.co/VOnvQ0SFrU
A randomized, phase IIa exploratory trial to assess efficacy of LEO 43204 in patients with AK. - PubMed - NCBI https://t.co/VOnvQ0SFrU
Randomized, phase IIa trial of the safety & efficacy of LEO 43204 in #actinickeratosis https://t.co/6s95HdbZeL #BJD https://t.co/uIDoIR6OOU